AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-188562366/world-new-york-interpublic.html" title="Facts and information about The World: New York - Interpublic and WPP win J&J holding pitch.(Johnson & Johnson)(Brief article)">The World: New York - Interpublic and WPP win J&J holding pitch.(Johnson & Johnson)(Brief article)</a>
Close
Set up an RSS feed that alerts you when new articles from Campaign are available.
Frequently asked questions about RSS feeds
The World: New York - Interpublic and WPP win J&J holding pitch.(Johnson & Johnson)(Brief article)
Interpublic and WPP have emerged as the winners of the holding company pitch for Johnson & Johnson's pharmaceutical business.
The drug giant spent about dollars 110 million of its dollars 1.4 billion measured media budget last year on pharmaceuticals, according to TNS Media Intelligence.
J&J's pharmaceutical brands include the pain reliever Ultram ER, the cancer and blood disease treatment Procrit and the migraine remedy Topomax.
The pitch process involved all the major holding ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Par Pharma gets FDA approval for generic Ultram ER
- News wire article from: AP Online November 16, 2009 700+ words
...approval for a generic version of Johnson & Johnson's extended-release chronic pain drug Ultram ER, and has started shipping the...or 3 percent, to $23.51. Ultram ER is sold by Johnson & Johnson's Ortho-McNeill...
- Ultram ER OK'd for pain.(NEWSLINE: Highlights of recent developments)(Brief...
- MPR Monthly Prescribing Reference April 1, 2006 700+ words
An extended-release formulation of tramadol has been made available by Ortho-McNeil and Biovail. Ultram ER (tramadol HCl extended-release tablets) has been approved for the treatment of moderate to moderately severe chronic pain in...
- IMPAX Sued Based on ANDA for Generic Ultram ER.
- Newspaper article from: Biotech Week August 27, 2008 700+ words
IMPAX Laboratories, Inc. announced Purdue Pharma Products L.P. ("Purdue Napp Pharmaceutical Group Ltd. ("Napp Biovail Laboratories International, SRL ("Biovail") and Ortho-McNeil, Inc. ("Ortho-McNeil") have filed suit for patent infringement in the United States District Court for the District of
- Biovail in tramadol deal with J&J unit.(Johnson & Johnson)(Brief Article)
- Newspaper article from: Pharma Marketletter November 14, 2005 700+ words
...agreement with Ortho-McNeil, a Johnson & Johnson company, for the marketing and...McNeil has retained an option for Ultram ER for other jurisdictions, excluding...will be known by the trade names Ultram ER and Ultram ODT respectively...
- Agency A-to-Z: the indispensable guide to healthcare agencies, including...
- Magazine article from: Medical Marketing & Media July 1, 2008 700+ words
...Elmiron, Ortho Evra, Ortho TriCyclen LO; Pricara: Aciphex, Ultram ER; Shire: Daytrana, Fosrenol, Vyvanse. Number of Accounts...Abraxis: Naropin; AZ: Merrem; Pricara: Tapentadol, Ultram ER; GSK: Levitra; GSK Consumer: Breathe Right, Niquitin...
- Once Daily ULTRAM(R) ER Extended-Release Tablets Now Available in the United...
- Press release article from: PR Newswire February 21, 2006 700+ words
...effects associated with ULTRAM ER were dizziness, nausea...somnolence, and flushing. ULTRAM ER Extended-Release Tablets...crushed, or split. ULTRAM ER should not be administered...Ortho-McNeil, Inc., a Johnson & Johnson company...
- Par claims patent win in dispute over pain drug
- News wire article from: AP Online August 17, 2009 700+ words
...patent dispute over the pain drug Ultram ER. The company wants to sell generic...while Biovail Corp. and a division of Johnson & Johnson collaborate in selling...decides to launch generic versions of Ultram ER. Biovail said it recorded $81...
- Labopharm Shares TumbleOn FDA Approvable Letter.
- Magazine article from: BIOWORLD Today Osborne, Randall October 2, 2006 700+ words
...to market with a once-daily tramadol when Ultram ER gained FDA approval in October 2005. Biovail...a unit of New Brunswick, N.J.-based Johnson & Johnson) and Purdue gives Ultram ER patent protection through 2014. Biovail...
